… informed consent and dissent only in the cases of patients under … The MacArthur Competence
Assessment Tool for clinical research … of patients with Alzheimer disease is very significant. …

… Generally, if a patient has both a durable power of attorney … At that point, the physician
must obtain informed consent from … financial capacity in patients with Alzheimer disease: a …

… more than one) determines that the patient is in a particular medical condition set out in
the law, such as a persistent vegetative state, advanced dementia or terminal illness, and is …

… In the situation where an individual lacks capacity, but has no close family or individual
with lasting power of attorney, then the Act allows for an Individual Mental Capacity Advocate (…

… they appoint a Lasting Power of Attorney or write an Advanced … Alzheimer's disease, concluding
the number of high-quality … ), although this has not been confirmed in clinical studies 25. …

… obtain informed consent prior to initiating a medical intervention. … : a durable power of attorney
for research participation, … among older persons with schizophrenia, Alzheimer disease, or …

… aim of this study was to explore views of ACP for people with dementia in the … Any available
medical trials … The need for it, particularly in terms of Lasting Power of Attorney over finance …

… This article explores the ways that discourse around Lasting Power of Attorney (LPA) under
… in lay and medical accounts of gaining power of attorney in the context of dementia, our …

… like living wills or lasting power of attorney, experts from outside the medical profession like
… GPs stated in interviews that they need sufficient knowledge about the dementia disease …

… at each clinic to four. We obtained informed consent from staff and indicated that we would
not … A common exception to this was lasting power of attorney and dementia as a progressive …